GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Trinity Biotech Plc (TRIB) [hlAlert]

Rating:
Outperform
TRIB
up 6.64 %

Trinity Biotech Plc (TRIB) rated Outperform by Raymond James

Posted on: Thursday,  Sep 3, 2015  10:25 AM ET by Raymond James

Raymond James rated Outperform Trinity Biotech Plc (NASDAQ: TRIB) on 09/03/2015, when the stock price was $14.90. Since
then, Trinity Biotech Plc has gained 6.64% as of 09/03/2015's recent price of $15.89.
If you would have followed this Raymond James's recommendation on TRIB, you would have gained 6.64% of your investment in 0 days.

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners. The Company has manufacturing facilities in Bray, Ireland and Lemgo, Germany, in Europe and in Jamestown, New York, Carlsbad, California and Kansas City, Missouri in the United States of America. During the year ended December 31, 2008, the Company sold 50% of product in the United States. Sales outside the United States, principally European and Asian/ African countries, represented 50%.

Our equity research team has gained national attention for stock-picking ability and analyst performance, with recognition in leading publications such as the Wall Street Journal and Institutional Investor magazine*. Raymond James’ equity research philosophy focuses on a fundamental approach that encompasses three basic points. First, we believe that superior research on select companies within well-defined industries is preferable to broad general coverage. Second, we concentrate on the identification of quality companies demonstrating solid growth potential, with the goal of helping our clients maximize their investment returns. Third, to help our clients take advantage of pockets of inefficiency in the market, we strive to locate superior companies from across the country that have the potential to provide our clients with unique opportunities.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/3/2015 10:25 AM Buy
None
14.90
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy